Wiley Periodicals, Inc

SHERPA: Unknown

People

  1. Antonescu
    Antonescu
  2. Wolden
    Wolden
  3. Cheung
    Cheung
  4. Modak
    Modak
  5. Dunkel
    Dunkel
  6. Kushner
    Kushner
  7. Kramer
    Kramer
  8. Wexler
    Wexler
  9. La Quaglia
    La Quaglia
  10. Sklar
    Sklar

Groups

  1. Pediatrics, Department of (430)
  2. GSK Faculty (252)
  3. Tow Center for Developmental Oncology (TCDO) (237)
  4. Center for Hematologic Malignancies (190)
  5. Survivorship Research (187)
  6. Department of Pathology and Laboratory Medicine (175)
  7. Pediatric Leukemia (150)
  8. Surgery (133)
  9. Neuroblastoma Service (119)
  10. Neuro-Oncology Service (114)
Search Within
Formats
  1. Journal Article (480)
  2. Meeting Abstract (247)
  3. Review (24)
  4. Correspondence (11)
  5. Guidelines (9)
  6. Editorial (5)
  7. Conference Paper (1)
  8. Miscellaneous (1)
  9. Research Letter (1)
Groups
  1. Pediatrics, Department of (430)
  2. GSK Faculty (252)
  3. Tow Center for Developmental Oncology (TCDO) (237)
  4. Center for Hematologic Malignancies (190)
  5. Survivorship Research (187)
  6. Department of Pathology and Laboratory Medicine (175)

More Groups

People
  1. Cristina Antonescu (104)
  2. Suzanne Wolden (74)
  3. Nai-Kong Cheung (70)
  4. Shakeel Modak (68)
  5. Brian Kushner (65)
  6. Ira Dunkel (65)

More People

Years
  1. 2025 (17)
  2. 2024 (29)
  3. 2023 (60)
  4. 2022 (57)
  5. 2021 (57)
  6. 2020 (56)

More Years

Publications
  1. Pediatric Blood and Cancer (544)
  2. Genes Chromosomes and Cancer (184)
  3. Developmental Dynamics (24)
  4. Wiley Interdisciplinary Reviews: Developmental Biology (7)
  5. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology (4)
  6. Echocardiography (3)

More Publications

Results (779)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • First experience of LOXO-292 in the management of pediatric patients with RET-altered cancers
    Meeting Abstract

    Ortiz, M. V.; Gerdemann, U.; Lee, Y. A.; Proust, S.; Henry, D.; Smith, S.; Rothenberg, S. M.; Raju, S. G.; Cox, M.; Glade Bender, J.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Safety and efficacy of intraventricular 131I-labeled monoclonal antibody 8H9 targeting the surface glycoprotein B7-H3
    Meeting Abstract

    Kramer, K.; Pandit-Taskar, N.; Donzelli, M.; Suzanne, W.; Zanzonico, P.; Humm, J.; Haque, S.; Souweidane, M.; Greenfield, J.; Carrasquillo, J.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Preliminary tolerability assessment of naxitamab (humanized anti-GD-2 monoclonal antibody) therapy in a phase 2 osteosarcoma trial
    Meeting Abstract

    Dela Cruz, F.; Chou, A.; Roberts, S.; Mauguen, A.; Bonura, J.; Hilliard, J.; Namuduri, M.; Ortiz, M.; Slotkin, E.; Wexler, L.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • High-dose naxitamab plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for high-risk neuroblastoma: Efficacy against histologically-evident primary refractory metastases in bone marrow
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) PLUS stepped-up dosing of granulocyte-macrophage colony-stimulating factor for neuroblastoma: Outpatient treament low immunogenicity, and major responses in a phase II trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for relapsed neuroblastoma resistant to salvage therapy: A phase II trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for consolidating >= 2nd complete remission of high-risk neuroblastoma
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Clinical impact of ALK mutations in neuroblastoma
    Meeting Abstract

    O'Donohue, T.; Gulati, N.; Shukla, N.; Roberts, S.; Basu, E.; Kushner, B.; Cheung, N. K.; Modak, S.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Clonal evolution in metastatic rhabdomyosarcoma
    Meeting Abstract

    Kinnaman, M.; Makohon-Moore, A.; Bouvier, N.; Glodzik, D.; Levine, M.; Papaemmanuil, E.; Dela Cruz, F.; Wexler, L.; Kung, A.; Iacobuzio-Donahue, C.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Neurologic complications from central nervous system neuroblastoma metastases
    Meeting Abstract

    Kramer, K.; Khakoo, Y.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save